Titles and Roles
- Professor, Department of Pathology and Laboratory Medicine
- Emory University School of Medicine
- Research Program
- Cancer Immunology
Periasamy Selvaraj, PhD, is a Professor in the Department of Pathology and Laboratory Medicine at Emory University School of Medicine. Dr. Selvaraj is also a co-founder of Metaclipse Therapeutics Corporation, a biotech company focusing on developing personalized immunotherapy for metastatic cancer.
Dr. Selvaraj earned his PhD in Biochemistry from Christian Medical College, Vellore and his MSc in Biochemistry from the University of Madras, Chennai, India. After obtaining his PhD, Dr. Selvaraj completed a postdoctoral fellowship at Dana-Farber Cancer Institute and Harvard Medical School, where he also served as an Instructor in the Department of Pathology. His postdoctoral work under the supervision of Dr. Timothy A. Springer focused on cell adhesion receptors of the immune system.
Dr. Selvaraj's laboratory focuses on a) developing personalized cancer vaccine-based immunotherapy approaches using a novel protein transfer technology and patients tumor tissue and b) studying the role and regulation of Fc receptors in antibody-mediated immunity and inflammation.
Dr. Selvaraj has published more than 90 research papers in national and international journals.
Publications Publication Date
In 2016, Dr. Selvaraj received the Emory 1% Award which recognizes Emory faculty whose National Institutes of Health (NIH) proposals have been ranked in the top 1% by NIH reviewers.